Altimmune, Inc. (NASDAQ:ALT) Q3 2025 Earnings Call Transcript November 6, 2025
Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.21264, expectations were $-0.29.
Operator: Good morning, ladies and gentlemen, and welcome to the Altimmune Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I’ll now introduce your host for today’s conference call, Lee Roth, President of Burns McClellan Investor Relations...
